Target intelligence / Profile preview

Ras-related protein Rab-43 (RAB43)

Target
RAB43
Molecular classification
Small GTPase, Enzyme, Member of the Ras oncogene family
01

Overview

Ras-related protein Rab-43 is a small GTPase enzyme and a member of the Rab family, which functions as a key regulator of intracellular membrane trafficking[1][3][7]. Rab-43 cycles between inactive GDP-bound and active GTP-bound forms, recruiting effectors that mediate transport vesicle formation, movement, tethering, and fusion with target membranes[1][7]. The protein is involved in retrograde transport, particularly from endocytic compartments to the Golgi apparatus, and is required for the structural integrity of the Golgi complex[1][3][7]. It also plays a role in maturation of phagosomes, notably those that engulf pathogens such as Staphylococcus aureus and Mycobacterium tuberculosis[1]. Although there are disease associations (e.g., certain cancers, Lynch syndrome 5, Smith-McCort dysplasia), there are currently no approved drugs listed as directly targeting this molecule[1][5][7].

Other names
RAB43Ras-related protein Rab-43RAB41Ras-related protein Rab-41RAB11BISY1
02

Mechanism of action

No drugs with defined mechanisms of action specifically targeting RAB43 are reported in public literature or databases[1][7].

03

Biological functions

GTPase activityIntracellular membrane trafficking, including transport vesicle formation, movement, tethering, fusionGolgi organization and structural integrityPhagosome maturationRetrograde transport, notably plasma membrane to Golgi, and endocytic pathway to GolgiCellular response to interferonTransport of Shiga toxin from early/recycling endosomes to trans-Golgi networkCarbohydrate derivative metabolismCell differentiation
04

Disease associations

Cancer (neoplasm)Lynch syndrome 5Smith-McCort dysplasiaPotential involvement in immune response and pathogen clearance (e.g., S. aureus, M. tuberculosis)Other: possible relevance in multiple tissues and biological processes (growth, metabolism, differentiation)
05

Safety considerations

None documented in the current literature; therapeutic safety profile not established due to the absence of direct pharmacological modulators[1][7].

Beyond the preview

Go deeper on Ras-related protein Rab-43 (RAB43).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ras-related protein Rab-43 (RAB43).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call